Stay updated on Nab-sirolimus in Severe PAH Clinical Trial
Sign up to get notified when there's something new on the Nab-sirolimus in Severe PAH Clinical Trial page.

Latest updates to the Nab-sirolimus in Severe PAH Clinical Trial page
- Check6 days agoChange DetectedNo additions or deletions were detected on the page.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check21 days agoChange DetectedRevision updated to v3.5.0 with v3.4.3 removed.SummaryDifference0.1%

- Check28 days agoChange DetectedRevision history updated: added v3.4.3 and removed v3.4.2. This change does not affect study data or page content.SummaryDifference0.1%

- Check35 days agoChange DetectedThe page layout has been updated with minor text changes; core study details such as eligibility criteria, interventions, and outcomes remain unchanged.SummaryDifference0.1%

- Check49 days agoChange DetectedThe updates appear to be cosmetic UI refinements to the study record page, with core sections such as Eligibility Criteria, Primary/Secondary Outcomes, and Enrollment unchanged. Overall study details remain the same, and no new or removed information is visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision: v3.4.2 appears on the page, replacing the prior v3.4.1 operational funding notice as part of routine site maintenance. This is a routine site maintenance update and does not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Nab-sirolimus in Severe PAH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nab-sirolimus in Severe PAH Clinical Trial page.